• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 485210 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413838977 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413838977 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Bristol-Myers Squibb: The Winning Streak Continues (BMY)

Published on Tue, 04/23/2013 - 14:13
By Peter Chu

Bristol-Myers Squibb (NYSE:BMY) traded today at a new 52-week high of $42.87. So far today approximately 7.2 million shares have been exchanged, as compared to an average 30-day volume of 10.1 million shares.

Bristol-Myers Squibb (NYSE:BMY) defies analysts with a current price ($42.39) 13.7% above its average consensus price target of $36.57. The stock should find initial support at its 50-day moving average (MA) of $38.96 and further support at its 200-day MA of $34.92.

In the past 52 weeks, shares of Bristol-Myers Squibb have traded between a low of $30.64 and a high of $42.87 and are now at $42.39, which is 38% above that low price. The 200-day and 50-day moving averages have moved 0.24% higher and 0.73% higher over the past week, respectively.

Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Tenaris: The Losing Streak Continues (TS...

Tenaris (NYSE:TS) traded at a new 52-week low today of $37.56. This new low was reache ...

Shares of TECO Energy Rise Above Previou...

TECO Energy (NYSE:TE) traded today at a new 52-week high of $18.78. This new high was ...

Shares of Teck Resources Fall to a New 5...

Teck Resources (NYSE:TCK) traded today at a new 52-week low of $15.15. This new low wa ...

Strayer Education Looks to Continue to T...

Strayer Education (NASDAQ:STRA) traded at a new 52-week high today of $67.03. Approxim ...

Shares of Sonic Rise to a New 52-Week Hi...

Sonic (NASDAQ:SONC) traded at a new 52-week high today of $24.00. This new high was re ...

Shares of Cia Siderurgica Nacional Fall ...

Cia Siderurgica Nacional (NYSE:SID) traded today at a new 52-week low of $3.32. Approx ...

Shares of Steven Madden Fall Below Previ...

Shares of Steven Madden (NASDAQ:SHOO) traded today at $28.02, breaking its 52-week low. ...

Shares of SAP Fall to a New 52-Week Low...

SAP (NYSE:SAP) traded today at a new 52-week low of $64.10. Approximately 2.3 million ...